Integrin-linked kinase (ILK): A 'hot' therapeutic target

Biochemical Pharmacology

Volumn 60, Issue 8, 2000, Pages 1115-1119

  Yoganathan, T Nathan ^a   Costello, Penny ^a   Chen, Xiaoyi ^a   Jabali, Mojgan ^a   Yan, Jun ^a   Leung, Dan ^a   Zhang, Zaihui ^a   Yee, Arthur ^a   Dedhar, Shoukat ^b,c   Sanghera, Jasbinder ^a  

^a Kinetek Pharmaceuticals Inc   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Integrin linked kinase; Phosphorylation; Protein kinase B; Serine threonine protein kinase; Transcriptional activation; Wnt signaling

Indexed keywords

BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; INTEGRIN; LYMPHOID ENHANCER FACTOR 1; PHOSPHATIDATE PHOSPHATASE; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CHROMOSOME 10Q; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 18244419034     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00444-5     Document Type: Article

References (26)

1. Giancotti F.G., Ruoslahti E. Integrin signaling. Science. 285:1999;1028-1032.
2. Hannigan G.E., Leung-Hagesteijn E.C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., Bell J.C., Dedhar S. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature. 379:1996;91-96.
3. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA. 95:1998;11211-11216.
4. Wu C., Keightley S.Y., Leung-Hagesteijn C., Radeva G., Coppolino M., Goicoechea S., McDonald J.A., Dedhar S. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem. 273:1998;528-536.
5. Radeva G., Petrocelli T., Behrend E., Leung-Hagesteijn C., Filmus J., Slingerland J., Dedhar S. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem. 272:1997;13937-13944.
6. Novak A., Hsu S.C., Leung-Hagesteijn C., Radeva G., Papkoff J., Montesano R., Roskelley C., Grosschedl R., Dedhar S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA. 95:1998;4374-4379.
7. Troussard A.A., Tan C., Yoganathan T.N., Dedhar S. Cell-extracellular matrix interactions stimulate the AP-1 transcriptional factor in an integrin-linked kinase and glycogen synthase kinase 3-dependent manner. Mol Cell Biol. 19:1999;7420-7427.
8. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609.
9. Eastman Q., Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol. 11:1999;233-240.
10. Hass-Kogan D., Shalev N., Wong M.M., Mills G., Yount G., Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol. 8:1998;1195-1198.
11. Coffer P., Jin J., Woodgett J.R. Protein kinase B (c-Akt) A multifunctional mediator of phosphatidylinositol 3-kinase activation . Biochem J. 335:1998;1-13.
12. Scheid M.P., Woodgett J.R. Protein kinases Six degrees of separation? Curr Biol. 10:2000;R191-R194.
13. Sizemore N., Leung S., Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/relA subunit. Mol Cell Biol. 19:1999;4798-4805.
14. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature. 401:1999;86-90.
15. Kane L.P., Shapiro V.S., Stokoe D., Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol. 9:1999;601-604.
16. Persad S., Attwell S., Gray V., Delcommenne M., Troussard A., Sanghera J., Dedhar S. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B-Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA. 97:2000;3207-3212.
17. Lynch D.K., Ellis C.A., Edwards P.A., Hiles I.D. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene. 18:1999;8024-8032.
18. Morimoto A.M., Tomlinson M.G., Nakatani K., Bolen J.B., Roth R.A., Herbst R. The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene. 19:2000;200-209.
19. Tonks N.K., Neel B.G. Form and function Signaling by protein tyrosine phosphatases . Cell. 87:1996;365-386.
20. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hobshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
21. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H., Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15:1997;356-362.
22. Wang S.S., Esplin E.D., Li J.L., Huang L., Gazdar A., Minna J., Evans G.A. Alteration of PPP2R1B gene in human lung and colon cancer. Science. 282:1998;284-287.
23. Di Cristofano A., Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell. 100:2000;387-390.
24. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., Parsons R. Germline mutation of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 16:1997;64-67.
25. Sun H., Lesche R., Li D.M., Liliental J., Zhang H., Gao J., Gavrilova N., Mueller B., Liu X., Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-triphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA. 96:1999;6199-6204.
26. Paramio J.M., Navarro M., Segrelles C., Gomez-Casero E., Jorcano J.L. PTEN tumor suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene. 18:1999;7462-7468.